• Skip to main content
  • Skip to footer
  • Connect With Us
  • Reservations

UEL | Saint Paul | University Enterprise Labs | Incubator | Start-Ups

  • Why UEL?
    • Equity and Inclusion
    • Benefits and Mission
    • UEL Companies
  • Facilities
    • Space at UEL
    • Amenities
    • COVID-19
  • Cool Stuff
    • Case Studies
    • Programming
    • Resources
    • Photo Gallery
  • Insights
  • About
    • UEL’s History
    • Board of Directors
    • UEL Team
    • UEL Success Stories
  • Partners
    • gBETA Affiliates
    • Partner Overview
    • Partnership Inquiry
    • UEL Companies
  • BARDA DRIVe
  • Connect With Us
  • Reservations
  • Residents
651-641-2804info@uelmn.org
Request Info

UEL Tenant Highlight: Xenamed

September 30, 2017

Xenamed is a pharmaceutical drug development company founded in 2016. Xenamed develops products at UEL and collaborates with contract manufacturing organizations for manufacturing clinical supplies, submission batches, and eventually commercialization. In addition to research and development, Xenamed manages every step of the FDA approval process for their products.

Xenamed develops both brand name and generic products for diverse therapeutic areas. They also work on several dosage forms other than tablets and capsules. Usually, these products have significant technical challenges.

In the short time in which Xenamed has been operating, Xenamed scientists have developed novel products and filed a number of patents in exciting therapeutic areas. Some of these products are being readied to be tested in the first human trials.

Currently, Xenamed employs formulators and analytical chemists and by the virtue of its model, its staff get a wide variety of experience beyond their particular expertise. This includes contributing to clinical, regulatory and production issues.  Xenamed also collaborates with the UMN on projects and provides internships.

Besides the science, Xenamed is looking to address patient needs and improve patient outcomes. With a full pipeline of projects, Xenamed provides an exciting working environment.

This UEL Highlight is by Amanda Hayward, a fourth-year Ph.D. candidate in the Biochemistry, Molecular Biology and Biophysics department at UMN-Twin Cities.  You can reach her at AHayward@uelmn.org. 

Filed Under: News

Footer

  • Latest News
  • Our Alumni

UEL is committed to the safety and well-being for all of our community.  Click here for our COVID-19 Preparedness Plan.

Click a logo to go to their webpage and more information on our associations


 

 



    

1000 Westgate Drive
Saint Paul, MN 55114
Map

651-641-2804

24-Hour Emergency

 

952-854-8800
info@uelmn.org

Keep in Touch

sign up for our monthly newsletter

Copyright © 2023 UEL MN | All Rights Reserved | Privacy Policy and Terms of Service | Minneapolis Web Design by BizzyWeb | Log in